Project Grant HT94252410101
Award Date 2/1/24
Completion Date 1/31/26
Dollars Obligated $700K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
- The Baylor College of Medicine will use a $1.6 million Project Grant from the Defense Health Agency to research germline variants and population-wide breast cancer risk. The grant was awarded on February 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). Through basic, applied, and advanced biomedical research, this project aims to transform healthcare for service members and the public by investigating medical solutions for the battlefield and developing...
- The Department of Defense's Defense Health Agency awarded a $1,127,375 Project Grant to The Washington University Office of Sponsored Research Services Division under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from Sep 30, 2023 to Sep 29, 2027, will fund research on "REPLICATION DRIVEN VULNERABILITIES IN CYCLIN E OVEREXPRESSING OVARIAN CANCERS". As a prominent research institution with expertise in biomedical sciences, The Washington...
- The Defense Health Agency has awarded a $862,751 Project Grant to the University of Wisconsin-Milwaukee (UWM) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective June 1, 2024 through May 31, 2027, will fund a research project to study the "Impact of Recent Childbirth on Breast Cancer Prognosis and Tumor Molecular Phenotypes Among Young Black and White Women." This grant supports UWM's ongoing biomedical research initiatives focused on...
- This Project Grant award of $447,625.00 was provided by the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), to The Washington University located in University City, Missouri. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public, with a focus on developing innovative medical solutions that address critical health challenges. The research will be conducted at...
- The U.S. Department of Defense's Defense Health Agency awarded a $693,000 Project Grant to Wayne State University in Detroit, Michigan under the Military Medical Research and Development program (CFDA 12.420). The grant supports the university's "EPIGENETIC THERAPEUTIC TARGETING OF ENHANCER HUBS FOR BREAST CANCER" research project, which aims to develop new treatments for breast cancer. The 3-year award, running from December 15, 2023 to December 14, 2026, will fund basic,...
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research by The Johns Hopkins University to investigate the impact of breast tissue microbiota on breast cancer progression. The total award amount is $1,553,332.00, with a performance period from October 1, 2025 to September 30, 2028. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing...
- The federal Project Grant award titled "LEVERAGING THE OVARIAN TUMOR MICROENVIRONMENT FOR EARLY DETECTION STRATEGIES" provides $466,500.00 in funding to The Washington University in University City, MO. The award is granted under the U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. This particular grant will fund...
- This $1,535,039 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development Program (CFDA 12.420) supports research conducted by Wake Forest University Health Sciences (WFUHS) to study how the breast tissue microbiota regulates immune checkpoint blockade therapy responsiveness in triple-negative breast cancer. The research aims to advance scientific understanding and develop new treatment approaches for this aggressive form of breast cancer that...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $894,125 to The Washington University in University City, Missouri to conduct research titled "UNDERSTANDING AND TARGETING EPIGENETIC VULNERABILITIES IN NF-1-MPNST". The research aims to transform healthcare for military service members, veterans, and the public by advancing innovative medical solutions. The award period runs from July 15, 2025 to...
- This Project Grant award of $1,401,794.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Oregon Health & Science University (OHSU). The funding will support a 3-year research project investigating the impact of recent childbirth on breast cancer prognosis and tumor molecular phenotypes among young Black and White women. The research aims to enhance understanding of breast cancer disease progression and outcomes in this...